EndNote™ 21: Accelerate your research

Leave the little tasks to us.
Join this free webinar on Feb 13 at 11AM IST.
Researchers routinely collaborate on a global scale, and the ability to work remotely is increasingly important.

Manually creating, maintaining, and sharing reference lists is time-consuming, particularly when managing input from collaborators.

EndNote 21, the world’s best reference manager, helps you save time, stay organized, collaborate with colleagues, and ultimately, get published.

With tools that simplify the process of finding and editing PDFs, automate bibliography creation, help with large-scale literature reviews, and allow sharing, you can focus on what matters most: your ideas.

Join us for this webinar to learn about how the newest version of EndNote- EndNote™ 21 facilitates research and manuscript writing.

The webinar will cover:
  • EndNote™ 21 layout and functionalities
  • Version Comparison with EndNote 20
  • Integration with Google Docs
  • Reference Formatting using EndNote™
  • Enhancements to EndNote Web

Register below and we'll send the details.



Dr. Subhasree Nag
Senior Business Solution Consultant

Dr.  Subhasree  Nag  is  a  senior  business  solution  consultant  for  the scholarly research and life sciences division at Clarivate.  

She  completed  her  PhD  from  Texas  Tech  University  Health  Sciences Center,  USA  and  her  post-doctoral  training  from  Pacific  Northwest National Laboratory, USA.

A pharmacologist and toxicologist by training, she has more than 8 years of  research  experience  in  anticancer  drug  discovery  and pharmacokinetics  areas  with  25  peer  reviewed  publications  and  more than 1500 citations.

At Clarivate, she is involved in promoting Clarivate's scholarly research, drug discovery and intellectual property (IP) solutions, conducting author and research capacity workshops, bespoke consulting projects, etc.

She  was  a  co-author  on  the  UGC-Good  Academic  Research  Practices guidance  document released  in  2020.  She  also  writes for  the  Clarivate pharma  industry  magazine,  Bioworld,  where  she  contributes  to  articles related to early-stage discovery and preclinical studies.